Cytotoxic Lanostane-Type Triterpenoids From the Fruiting Bodies of Ganoderma Lucidum and Their Structure–activity Relationships

Oncotarget - United States
doi 10.18632/oncotarget.14336
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Anti-Human Immunodeficiency Virus-1 Protease Activity of New Lanostane-Type Triterpenoids From Ganoderma Sinense

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
2009English

Enhanced Production of Polysaccharides and Triterpenoids in Ganoderma Lucidum Fruit Bodies on Induction With Signal Transduction During the Fruiting Stage

PLoS ONE
Multidisciplinary
2018English

Structure and Immunological Activity of a Novel Polysaccharide From the Spores of Ganoderma Lucidum

African Journal of Biotechnology
2011English

Ganoderic Acids T, S and R, New Triterpenoids From the Cultured Mycelia of Ganoderma Lucidum.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1986English

Norlanostane and Lanostane Glycosides From the Bulbs of Chionodoxa Luciliae and Their Cytotoxic Activity

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
2003English

Effect of 26-Oxygenosterols From Ganoderma Lucidum and Their Activity as Cholesterol Synthesis Inhibitors

Applied and Environmental Microbiology
Applied MicrobiologyBiotechnologyEcologyFood Science
2005English

The Pharmacological Effects of Triterpenoids From ≪i>Ganoderma Lucidum</I> And the Regulation of Its Biosynthesis

Advances in Biological Chemistry
2020English

Discovery of Ganoderma Lucidum Triterpenoids as Potential Inhibitors Against Dengue Virus NS2B-NS3 Protease

Scientific Reports
Multidisciplinary
2019English

Meroterpenoids With Protein Tyrosine Phosphatase 1B Inhibitory Activities From the Fruiting Bodies of Ganoderma Ahmadii

Frontiers in Chemistry
Chemistry
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy